Bionik Laboratories Corp. announced the appointment of Richard Russo, Jr. as Chief Executive Officer, previously served as Chief Financial Officer. appointment is effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 12 | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+2.50% | 41.61B | |
+19.93% | 31.07B | |
+10.90% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- BNKL Stock
- News Bionik Laboratories Corp.
- Bionik Laboratories Corp. Appoints Richard Russo as Chief Executive Officer